176 related articles for article (PubMed ID: 18072075)
1. Relationship between endogenous parathyroid hormone and bone metabolism/geometry in female patients treated with glucocorticoid.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Horm Metab Res; 2008 Jan; 40(1):60-5. PubMed ID: 18072075
[TBL] [Abstract][Full Text] [Related]
2. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys.
Fox J; Miller MA; Newman MK; Recker RR; Turner CH; Smith SY
Bone; 2007 Sep; 41(3):321-30. PubMed ID: 17573250
[TBL] [Abstract][Full Text] [Related]
3. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
4. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur.
Fox J; Miller MA; Recker RR; Turner CH; Smith SY
Calcif Tissue Int; 2007 Jul; 81(1):53-63. PubMed ID: 17551766
[TBL] [Abstract][Full Text] [Related]
5. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT
Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
[TBL] [Abstract][Full Text] [Related]
6. [Glucocorticoids and osteoporosis].
Zikán V
Vnitr Lek; 2007; 53(7-8):831-40. PubMed ID: 17915428
[TBL] [Abstract][Full Text] [Related]
7. Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects.
Chen Q; Kaji H; Iu MF; Nomura R; Sowa H; Yamauchi M; Tsukamoto T; Sugimoto T; Chihara K
J Clin Endocrinol Metab; 2003 Oct; 88(10):4655-8. PubMed ID: 14557436
[TBL] [Abstract][Full Text] [Related]
8. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone.
Sosa M; Jódar E; Saavedra P; Navarro MC; Gómez de Tejada MJ; Martín A; Peña P; Gómez J
Eur J Intern Med; 2008 Jan; 19(1):51-6. PubMed ID: 18206602
[TBL] [Abstract][Full Text] [Related]
10. Low density lipoprotein-cholesterol levels affect vertebral fracture risk in female patients with primary hyperparathyroidism.
Kaji H; Hisa I; Inoue Y; Sugimoto T
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):371-6. PubMed ID: 19609845
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of bone metabolic indices for the prediction of changes in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism.
Kaji H; Nomura R; Yamauchi M; Chihara K; Sugimoto T
Horm Metab Res; 2006 Jun; 38(6):411-6. PubMed ID: 16823724
[TBL] [Abstract][Full Text] [Related]
12. Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects.
Paz-Pacheco E; Fuleihan GE; LeBoff MS
J Bone Miner Res; 1995 Nov; 10(11):1713-8. PubMed ID: 8592948
[TBL] [Abstract][Full Text] [Related]
13. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
Cejka D; Jäger-Lansky A; Kieweg H; Weber M; Bieglmayer C; Haider DG; Diarra D; Patsch JM; Kainberger F; Bohle B; Haas M
Nephrol Dial Transplant; 2012 Jan; 27(1):226-30. PubMed ID: 21613383
[TBL] [Abstract][Full Text] [Related]
14. Severe cortical and trabecular osteopenia in secondary hyperparathyroidism.
Brancaccio D; Di Leo C; Bestetti A; Carpani P; Tagliabue L; Cozzolino M; Galassi A; Luigi Tarolo G; Gallieni M
Hemodial Int; 2003 Apr; 7(2):122-9. PubMed ID: 19379351
[TBL] [Abstract][Full Text] [Related]
15. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone secretion in women in late menopause submitted to EDTA-induced hypocalcemia.
Pereira LC; Pereira FA; Sá MF; Foss MC; de Paula FJ
Maturitas; 2008 Jan; 59(1):91-4. PubMed ID: 18037250
[TBL] [Abstract][Full Text] [Related]
17. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1.
Bodine PV; Seestaller-Wehr L; Kharode YP; Bex FJ; Komm BS
J Cell Physiol; 2007 Feb; 210(2):352-7. PubMed ID: 17044082
[TBL] [Abstract][Full Text] [Related]
18. [A clinical study of abnormal bone metabolism in patients with HBV liver cirrhosis].
Wang YG; Liu Q; Wang WQ; Chen ZP; Yan MX
Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):33-6. PubMed ID: 16420762
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
Heijckmann AC; Huijberts MS; Schoon EJ; Geusens P; de Vries J; Menheere PP; van der Veer E; Wolffenbuttel BH; Stockbrugger RW; Dumitrescu B; Nieuwenhuijzen Kruseman AC
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):740-7. PubMed ID: 18617778
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticosteroid-induced osteoporosis in adult primiparous Göttingen miniature pigs: effects on bone mineral and mineral metabolism.
Scholz-Ahrens KE; Delling G; Stampa B; Helfenstein A; Hahne HJ; Açil Y; Timm W; Barkmann R; Hassenpflug J; Schrezenmeir J; Glüer CC
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E385-95. PubMed ID: 17456640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
